LIGAND PHARMACEUTICALS INCORPORATED Co Selected Measure Amt
LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) reported Co Selected Measure Amt of $268.09 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-21.
Financial Statements › Notes
ecd:CoSelectedMeasureAmt · last filed 2026-04-21
| Period end | Co Selected Measure Amt 12 month |
|---|---|
| 2025-12-31 | $268.09M DEF 14A · filed 2026-04-21 |
| 2024-12-31 | $167.13M DEF 14A · filed 2026-04-21 |
| 2023-12-31 | $131.31M DEF 14A · filed 2026-04-21 |
| 2022-12-31 | $196.25M DEF 14A · filed 2026-04-21 |
| 2021-12-31 | $241.54M DEF 14A · filed 2026-04-21 |